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Abstract 
Background: Nucleotide sugars serve as sugar donors for the synthesis of various glycones. The biological and 
chemical properties of glycones can be altered depending which sugar is attached. Bacteria synthesize unusual 
nucleotide sugars. A novel nucleotide sugar can be synthesized in Escherichia coli by introducing nucleotide biosyn‑
thetic genes from other microorganisms into E. coli. The engineered E. coli strains can be used as a platform for the 
synthesis of novel glycones.
Results: Four genes, Pdeg (UDP‑N‑acetylglucosamine C4,6‑dehydratase), Preq (UDP‑4‑reductase), UDP‑GlcNAc 6‑DH 
(UDP‑N‑acetylglucosamine 6‑dehydrogenase), and UXNAcS (UDP‑N‑acetylxylosamine synthase), were employed 
to synthesize UDP‑quinovosamine, UDP‑N‑acetylglucosaminuronic acid, and UDP‑N‑acetylxylosamine in E. coli. We 
engineered an E. coli nucleotide sugar biosynthetic pathway to increase the pool of substrate for the target nucleotide 
sugars. Uridine diphosphate dependent glycosyltransferase (UGT) was also selected and introduced into E. coli. Using 
engineered E. coli, high levels of three novel flavonoid glycosides were obtained; 158.3 mg/L quercetin 3‑O‑(N‑acetyl)
quinovosamine, 172.5 mg/L luteolin 7‑O‑(N‑acetyl)glucosaminuronic acid, and 160.8 mg/L quercetin 3‑O‑(N‑acetyl)
xylosamine.
Conclusions: We reconstructed an E. coli nucleotide pathway for the synthesis of UDP‑quinovosamine, UDP‑N‑acetyl‑
glucosaminuronic acid and UDP‑N‑acetylxylosamine in an E. coli galU (UDP‑glucose 1‑phosphate uridylyltransferase) 
or pgm (phosphoglucomutase) deletion mutant. Using engineered E. coli strains harboring a specific UGT, three novel 
flavonoids glycones were synthesized. The E. coli strains used in this study can be used for the synthesis of diverse 
glycones.
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Background
Attachment of diverse sugar molecules to secondary 
metabolites such as antibiotics and phytochemicals is of 
interest because the biological activities of glycones are 
often modulated by sugar molecules [1–4]. Flavonoids, 
a major group of phytochemicals, are synthesized using 
the phenylpropanoid pathway [5]. Most flavonoids exit as 
glycones. Attachment of sugars to flavonoids is mediated 
by nucleotide (usually uridine diphosphate or thymi-
dine diphosphate) sugar- dependent glycosyltransferases 
(GT); GTs use nucleotide sugars as sugar donors and var-
ious molecules including flavonoids as sugar-acceptors 
[6]. The diversity of sugars found in flavonoids is limited 
because plants contain only UDP-glucose, UDP-glucu-
ronic acid, UDP-rhamnose, UDP-xylose, and UDP-ara-
binose [7]. UDP-glucose is a substrate for the synthesis 
of other UDP-sugars in plants [8, 9]. It is converted to 
UDP-glucuronic acid, UDP-xylose, and UDP-arabinose 
by the action of UDP-glucose dehydrogenase (UGD), 
UDP-xylose synthase (UXS), and UDP-xylose epimerase 
(UXE), respectively. The pathway from UDP-glucuronic 
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acid to UDP-arabinose is present in plants but is absent 
in bacteria. In plants and bacteria, nucleotide-rhamnose 
exists in different forms. In plants, UDP-rhamnose is 
synthesized from UDP-glucose by one multifunctional 
enzyme (rhamnose synthase, RHM) whereas in bacteria, 
TDP-rhamnose is synthesized from TDP-glucose in three 
steps by three different enzymes [10].
Bacteria synthesize unique nucleotide sugars that are 
not found in plants. Bacteria have a nucleotide pathway 
starting from glucosamine 1-phosphate. Glucosamine 
1-phosphate is a precursor to UDP-N-acetylglucosamine 
(UDP-GlcNAc), which is eventually used in peptidoglycan 
biosynthesis [11]. The pathway toward UDP-GlcNAc is 
well defined in most bacteria. In some bacteria, UDP-Glc-
NAc is converted to other UDP-N-acetyl sugars. Bacillus 
cereus ATCC 14579 contains two genes (Pdeg and Preq) 
for the biosynthesis of UDP-quinovosamine from UDP-
GlcNAc; Pdeg encodes an enzyme (UDP-N-acetylglu-
cosamine C4,6-dehydratase) that converts UDP-GlcNAc 
to UDP-4-keto-4,6-d-deoxy-GlcNAc (UDP-2-acetamido-
2,6-dideoxy-α-d-xylo-4-hexulose) and Preq encodes a 
UDP-4-reductase that converts UDP-4-keto-4,6-d-deoxy-
GlcNAc to UDP-N-acetylquinovosamine (Fig.  1) [12]. B. 
cereus NVH 391-98 also synthesizes a unique nucleotide 
sugar from UDP-GlcNAc. This species synthesizes UDP-
N-acetylxylosamine via UDP-N-acetylglucosaminuronic 
acid from UDP-GlcNAc (Fig.  1) [13], which pathway is 
very similar to the pathway from UDP-glucose to UDP-
xylose in plants [10]. With the completion of genome pro-
jects on diverse microorganisms, genes for the synthesis 
of these nucleotide sugars have been annotated but the 
functional characterization of only a few of them has been 
carried out [13–16]. If these genes could be adapted to 
function in Escherichia coli, novel nucleotide sugars and 
hence novel glycones could be synthesized in E. coli.
Synthetic and semi-synthetic approaches to diverse gly-
cones have more disadvantages than advantages, because 
these methods can produce complex mixtures and has 
a limited ability to confer regioselectivity or stereose-
lectivity to glycones [17]. Recently, glycosylation using 
biocatalysts such as uridine diphosphate dependent gly-
cosyltransferase (UGT) has been used to produce diverse 
glycones [18, 19]. By engineering nucleotide pathways 
in E. coli, it is feasible to synthesize novel glycones. Our 
group has previously used flavonoids as sugar acceptor to 
create novel flavonoid glycones [20]. Here, we reported 
on the synthesis of three additional novel flavonoid gly-
cones using an engineered E. coli strain.
Methods
Constructs
For the synthesis of UDP-quinovosamine, genomic DNA 
from B. cereus ATCC 14579 was isolated and used as a 
template for polymerase chain reaction (PCR). Both 
Pdeg and Preq (GenBank AE016877.1) were cloned using 
5′-CGGCATATGTTAAATAAAATAATTTTAATT-3′ 
(the NdeI site is underlined) as the forward primer and 
5′-CATCTCGAGTCATCGCAAAAACCCTCCTTT-3′ 
as the reverse primer (the XhoI site is underlined). The 
resulting PCR product was digested with NdeI/XhoI and 
subcloned into the corresponding sites of pACYCDuet, 
pCDFDuet, and pETDuet. The resulting constructs were 
named pA-DHR, pC-DHR, and pE-DHR, respectively 
(Table 1). The AtUGT78D2 gene, which was cloned pre-
viously [21], was subcloned into the EcoRI/NotI sites of 
pACYCDuet, pCDFDuet, and pETDuet, all of which 
contained UDP-GlcNAcD at the NdeI/XhoI sites. The 
constructs were named pA-DHR-D2, pC-DHR-D2, or 
pE-DHR-D2, respectively (Table 1).
UDP-N-acetylglucosamine 6-dehydrogenase (UDP-
GlcNAc 6-DH, GenBank GU784842) and UDP-
N-acetylxylosamine synthase (UXNAcS, GenBank 
accession number GU784843) from B. cereus NVH 
391–98 were synthesized after codon optimization for 
E. coli (Bioneer, Korea; The codon optimized sequences 
of two genes are available in Additional file  1). UDP-
GlcNAc 6-DH was subcloned into the EcoRI/NotI sites 
of pACYCDuet, pCDFDuet, and pETDuet. The corre-
sponding constructs were named pA-6-DH, pC-6-DH, 
and pE-6-DH, respectively (Table 1). UXNAcS was sub-
cloned into the NdeI/XhoI site of pA-6-DH, pC-6-DH, 
or pE-6-DH and the resulting constructs were named 
pA-6-DH-UXNAcS, pC-6-DH-UXNAcS, and pE-6-DH-
UXNAcS, respectively.
Previously cloned AmUGT10 from Antirrhinum majus 
(GenBank accession number AB362988) [22] was sub-
cloned into the NdeI/XhoI sites of pA-6-DH, pC-6-DH, 
and pE-6-DH. The resulting constructs were named 
pA-6-DH-AmUGT, pC-6-DH-AmUGT, and pE-6-DH-
AmUGT, respectively.
Molecular modeling
Comparative modeling software PRIME incorporated 
into the Schrödinger molecular modeling software suite 
was used to generate a 3D structure of the AtUGT78D2. 
The crystallographic structure of the flavonoid 3-O-glu-
cosyltransferase (VvGT, PDB 2C1X) [23] was used as 
a template (sequence similarity  =  56  %). The optimal 
model was selected based on bond angle stereochem-
istry using PROCHECK. After refinement of the loop 
structures, the model was subjected to energy minimiza-
tion and molecular dynamics simulations (MD) in order 
to obtain a stable, low-energy conformation. Energy 
minimization was performed using a conjugate gradi-
ent minimization (0.05 convergence criteria), the OPLS-
AA force field, and the GB/SA continuum water model. 
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MD simulations were performed by pre-equilibration for 
100 ps and simulation for 1 ns at 300 K with a 1-fs time 
step and SHAKE applied to all bonds to hydrogen. 3D 
structures of UPD-2-acetamido-2,6-dideoxy-β-d-glucose 
(UDP-N-acetylquinovosamine) and UDP-2-acetamido-
2-deoxy-β-d-xylose (UDP-N-acetylxylosamine) were 
prepared by modification of UDP-2-deoxy-2-fluoro-α-
d-glucose obtained from the crystal structure of 2C1Z 
(VvGT flavonoid 3-O-glucosyltransferase) [23]. The mod-
eled UDP sugars were then merged into the AtUGT78D2 
structure to provide AtUGT78D2 complexed with UDP-
N-acetylquinovosamine and UDP-N-acetylxylosamine, 
respectively. With the modeled structure, docking of 
quercetin was carried out using the GLIDE program 
incorporated into the Schrödinger molecular mod-
eling software suite (http://www.schrodinger.com). The 
default setting of the extreme precision mode of GLIDE 
was employed for the docking, and up to 10 poses were 
saved for analysis. All of the saved poses were similar and 
therefore, the highest scored pose was selected for bind-
ing mode analysis.
Biosynthesis of flavonoid glycosides in E. coli
An overnight culture of E. coli transformant was inoc-
ulated into LB (Luria–Bertani) medium containing 
the appropriate antibiotics and grown at 37  °C until 
it reached an OD600 of 0.8. IPTG (isopropyl β-D-1-
thiogalactopyranoside) was added at a final concentra-
tion of 1  mM and the culture was incubated at 18  °C 
for 24  h with shaking at 180  rpm. Cells were harvested 
by centrifugation and resuspended in M9 medium con-
taining 2 % glucose and antibiotics. At this time, the cell 
concentration was adjusted to 2.0 at OD600. The substrate 
was added to the reaction medium at a final concentra-
tion of 100 μM and the mixture was incubated at 30  °C 
for 20 h. The reaction was carried out in 2 mL medium 
in a test tube (14 mm × 145 mm). The supernatant was 
boiled for 3 min, centrifuged at 15,000g for 15 min, and 
then analyzed using high performance liquid chromatog-
raphy (HPLC) [24]. To monitor the production of each 
compound, reaction was performed in a 250  mL flask 
containing 50 mL reaction mixture.
The structures of reaction products were determined 
using nuclear NMR [25]. The reaction product was 
purified as described in An et al. [26]. Quercetin 3-O-(N-
acetyl) quinovosamine: 1H NMR (400  MHz, DMSO-d6) 
δ ppm 7.67 (d, J =  2.2  Hz, 1H, H-2′), 7.62 (dd, J =  8.5, 
2.2  Hz, 1H, H-6′), 6.86 (d, J  =  8.5  Hz, 1H, H-5′), 6.40 
(d, J = 2.1 Hz, H-8), 6.20 (d, J = 2.1 Hz, 1H, H-6), 5.35 
(d, J = 8.5 Hz, 1H, H-1″), 3.96 (dd, J = 10.2, 8.5 Hz, 1H, 
H-2″), 3.43 (dd, J  =  10.2, 8.7  Hz, 1H, H-3″), 3.22 (dq, 
J = 9.2, 6.1 Hz, 1H, H-5″), 3.05 (t, J = 9.2 Hz, 1H, H-4″), 
2.06 (s, 3H, H-8″), 1.11 (d, J  =  6.1  Hz, 3H); 13C NMR 
(100  MHz, DMSO-d6) δ ppm 179.4 (C-4), 174.5 (C-7″), 
166.1 (C-7), 163.2 (C-5), 159.0 (C-9), 158.5 (C-2), 149.9 
(C-4′), 146.0 (C-3′), 135.3 (C-3), 123.4 (C-6′), 123.3 (C-1′), 
117.5 (C-2′), 116.2 (C-5′), 105.9 (C-10), 101.6 (C-1″), 
100.0 (C-6), 94.8 (C-8), 77.4 (C-4″), 76.4 (C-3″), 73.9 
(C-5″), 58.4 (C-2″), 23.3 (C-8″), 18.0 (C-6″).
Luteolin-7-O-(N-acetyl)glucosaminuronic acid; 1H NMR 
(400 MHz, DMSO-d6): δ 7.87 (d, J = 8.9 Hz, 1H), 7.44 (s, 
1H), 7.42 (d, J = 8.4 Hz, 1H), 6.89 (d, J = 8.3 Hz, 1H), 6.72 
(s, 2H), 6.33 (s, 1H), 5.21 (d, J =  8.4  Hz, 1H), 3.69–3.78 
(m, 2H), 3.46 (t, J = 9.3 Hz, 1H), 3.28–3.33 (m, 1H), 1.81 
(s, 3H); 13C NMR (100 MHz, DMSO-d6): δ 182.4, 172.0, 
170.0, 165.1, 163.3, 161.7, 157.5, 150.7, 146.5, 121.7, 119.6, 
116.6, 114.2, 106.0, 103.5, 100.0, 98.8, 95.2, 75.0, 74.2, 72.9, 
55.5, 23.6
Quercetin-3-O-(N-acetyl)xylosamine. 1H NMR (400   
MHz, DMSO-d6): δ 12.67 (s, 1H), 8.03 (d, J  =  8.7  Hz, 
1H), 7.65 (dd, J =  8.4, 2.1  Hz, 1H), 7.59 (d, J =  2.1  Hz, 
1H), 6.85 (d, J = 8.5 Hz, 1H), 6.42 (d, J = 1.9 Hz, 1H), 6.31 
(d, J = 1.9 Hz, 1H), 5.47 (d, J = 7.8 Hz, 1H), 3.77–3.85 (m, 
1H), 3.69 (dd, J =  11.7, 4.1  Hz, 1H), 3.27-3.51 (m, 2H), 
2.94–2.99 (m, 1H), 1.89 (s, 3H); 13C NMR (100  MHz, 
DMSO-d6): δ 178.6, 170.7, 165.4, 162.4, 157.4, 157.1, 
149.9, 146.1, 134.2, 123.1 122.0, 117.1, 116.7, 105.0, 104.8, 
101.1, 94.7, 74.7, 71.2, 67.2, 56.3, 24.5.
Results
Synthesis of quercetin 3‑O‑quinovosamine in Escherichia 
coli
Bacillus cereus ATCC 14579 has a nucleotide biosyn-
thetic pathway to synthesize UDP-N-acetylquinovosa-
mine from UDP-N-acetyl-d-glucosamine by Pdeg and 
Preq [12] (Fig. 1a). Introduction of two genes (Pdeg and 
Preq) for the biosynthesis of UDP-N-acetylquinovo-
samine into E. coli could lead to the synthesis of a new 
(See figure on previous page.) 
Fig. 1 a Nucleotide sugar biosynthesis pathway of Escherichia coli. UDP‑glucose to UDP‑N‑acetyl‑d‑glucosamine is an endogenous pathway. Genes 
introduced into E. coli to synthesize UDP‑2‑acetamide‑2,6‑dideoxy‑β‑l‑arabinos‑hex‑4‑ulose, UDP‑N‑acetylquinovosamine, UDP‑N‑acetyl‑d‑glucosa‑
minuronic acid, and UDP‑N‑acetyl‑d‑xylosamine are indicated in the gray box. galU UDP‑glucose 1‑phosphate uridylyltransferase; pgm phospho‑
glucomutase; pgi phosphoglucoisomerase; glmS l‑glutamate d‑fructose 6‑phosphate aminotransferase; glmM phophoglucosamine mutase; glmU 
glucosamine‑1‑phosphate acetyltransferase; UDP-GlcNAc 6-DH UDP‑N‑acetylglucosamine 6‑dehydrogenase; UXNAcS UDP‑N‑acetylxylosamine 
synthase; Pdeg UDP‑N‑acetylglucosamine C4,6‑dehydratase; Preq UDP‑4‑reductase. b Reaction scheme of synthesis of quercetin 3‑O‑(N‑acetyl) 
quinovosamine, quercetin 3‑O‑(N‑acetyl) xylosamine, and luteolin O‑(N‑acetyl)glucosaminuronic acid
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nucleotide sugar that does not naturally exist in E. coli, 
and the resulting nucleotide-sugar could be a sugar donor 
for synthesis of a novel flavonoid glycoside (Fig.  1b). In 
order to synthesize flavonoid N-acetylquinovosamine in 
E. coli, we needed to find a UGT that conjugates a flavo-
noid and UDP-N-acetylquinovosamine. We conducted 
molecular docking because the nucleotide-sugar syn-
thesized by UDP-(N-acetyl)quinovosamine was not 
commercially available. The UDP-(N-acetyl)quinovo-
samine was fitted into the active site of AtUGT78D2. 
The side chain of Asp380 formed a hydrogen bond with 
the 3-hydroxy group of glucose, and the nitrogen in the 
Table 1 Plasmids and strains used in the present study
Plasmids or E. coli strain Relevant properties or genetic marker Source or references
Plasmids
 pACYCDuet P15A ori, Cmr Novagen
 pCDFDuet CDF ori, Strr Novagen
 pETDuet f1 ori, Ampr Novagen
 pGEX 5X‑2 pBR322 ori, Ampr GE healthcare
 pA‑DHR pACYCDuet + Pdeg and Preq from B. cereus ATCC 14579 This study
 pC‑DHR pCDFDuet + Pdeg and Preq from B. cereus ATCC 14579 This study
 pE‑DHR pETDuet + Pdeg and Preq from B. cereus ATCC 14579 This study
 pA‑DHR‑D2 pACYCDuet + Pdeg and Preq from B. cereus ATCC 14579 + AtUGT78D2 This study
 pC‑DHR‑D2 pCDFDuet + Pdeg and Preq from B. cereus ATCC 14579 + AtUGT78D2 This study
 pE‑DHR‑D2 pETDuet + Pdeg and Preq from B. cereus ATCC 14579 + AtUGT78D2 This study
 pA‑6‑DH pACYCDuet + UDP‑N‑acetylglucosamine 6‑dehydrogenase (UDP‑GlcNAc 6‑DH) from B. cereus NVH 
391–98
This study
 pC‑6‑DH pCDFDuet + UDP‑N‑acetylglucosamine 6‑dehydrogenase (UDP‑GlcNAc 6‑DH) from B. cereus NVH 
391–98
This study
 pE‑6‑DH pETDuet + UDP‑N‑acetylglucosamine 6‑dehydrogenase (UDP‑GlcNAc 6‑DH) from B. cereus NVH 
391–98
This study
 pA‑6‑DH‑UXNAcS pACYCDuet + UDP‑N‑acetylglucosamine 6‑dehydrogenase (UDP‑GlcNAc 6‑DH) from B. cereus NVH 
391–98 + UDP‑N‑acetylxylosamine synthase (UXNAcS) from B. cereus NVH 391–98
This study
 pC‑6‑DH‑UXNAcS pCDFDuet + UDP‑N‑acetylglucosamine 6‑dehydrogenase (UDP‑GlcNAc 6‑DH) from B. cereus NVH 
391–98 + UDP‑N‑acetylxylosamine synthase (UXNAcS) from B. cereus NVH 391–98
This study
 pE‑6‑DH‑UXNAcS pETDuet + UDP‑N‑acetylglucosamine 6‑dehydrogenase (UDP‑GlcNAc 6‑DH) from B. cereus NVH 
391–98 + UDP‑N‑acetylxylosamine synthase (UXNAcS) from B. cereus NVH 391–98
This study
 pC‑6‑DH‑AmUGT pCDFDuet + UDP‑N‑acetylglucosamine 6‑dehydrogenase (UDP‑GlcNAc 6‑DH) from B. cereus NVH 
391–98 + UGT10 from A. majus
This study
 pG‑D2 pGEX5x‑2 + AtUGT78D2 [17]
Strains
 BL21 (DE3) F− ompT hsdSB(rB
− mB
−) gal dcm lon (DE3) Novagen
 Bpgm BL21(DE3) Δpgm [17]
 BgalU BL21(DE3) ΔgalU [17]
 QS‑1 BL21(DE3) harboring pC‑DHR‑D2 This study
 QS‑2 Bpgm harboring pC‑DHR‑D2 This study
 QS‑3 BgalU harboring pC‑DHR‑D2 This study
 QS‑4 BgalU harboring pC‑DHR‑D2 and pE‑DHR This study
 LNAGA‑1 BL21(DE3) harboring pC‑6DH‑D2‑AmUGT This study
 LNAGA‑2 BgalU harboring pC‑6DH‑D2‑AmUGT This study
 LNAGA‑3 Bpgm harboring pC‑6DH‑D2‑AmUGT This study
 QNX‑1 BL21(DE3) harboring pA‑6‑DH‑UXNAcS and pG‑D2 This study
 QNX‑2 BL21(DE3) harboring pC‑6‑DH‑UXNAcS and pG‑D2 This study
 QNX‑3 Bpgm harboring pA‑6‑DH‑UXNAcS and pG‑D2 This study
 QNX‑4 Bpgm harboring pC‑6‑DH‑UXNAcS and pG‑D2 This study
 QNX‑5 BgalU harboring pA‑6‑DH‑UXNAcS and pG‑D2 This study
 QNX‑6 BgalU harboring pC‑6‑DH‑UXNAcS and pG‑D2 This study
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backbone of Trp359 forms a hydrogen bond with the 
4-hydroxy group of glucose. The methyl group of the 
acetamido of UDP-N-acetylquinovosamine interacted 
hydrophobically with Phe238, Gln381, and Met288. 
The methyl group at carbon 5 interacted hydrophobi-
cally with the backbone of THr145 and the side chain of 
Ala146. Therefore, UDP-N-acetylquinovosamine binds to 
AtUGT78D2 (Fig. 2a). For this reason, AtUGT78D2 was 
used as glycosyltransferase for the synthesis of flavonoid 
N-acetylquinovosamine.
In order to make a novel flavonoid glycoside, Pdeg and 
Preq from B. cereus along with a flavonoid glycosyltrans-
ferase, AtUGT78D2, were introduced into E. coli. The 
resulting strain (QS-1) was used for the biotransforma-
tion of quercetin. HPLC analysis of the reaction product 
showed two new peaks (Fig.  3). P1 exhibited the same 
retention time as quercetin 3-O-(N-acetyl)glucosamine 
while P2 had a different retention time with a molecular 
mass of 489.1 Da which was the expected molecular mass 
of quercetin 3-O-(N-acetyl)quinovosamine. The molecu-
lar structure of the reaction product was analyzed using 
NMR and determined to be quercetin 3-O-(N-acetyl)
quinovosamine.
The biotransformation of quercetin using strain QS-1 
produced two products, quercetin 3-O-N-acetylglu-
cosamine and quercetin 3-O-(N-acetyl)quinovosa-
mine in a ratio of 54–46 (Fig. 4). The higher production 
of quercetin 3-O-(N-acetyl)glucosamine compared 
quercetin 3-O-(N-acetyl)quinovosamine was because 
AtUGT78D2 showed higher affinity to UDP-N-acetyl-
glucosamine [21]. In order to increase the production of 
quercetin 3-O-(N-acetyl)quinovosamine over quercetin 
3-O-(N-acetyl)glucosamine, we decided to increase the 
pool of UDP-N-acetylglucosamine. We used two E. coli 
Fig. 2 a Docking of UDP‑N‑acetylquinovosamine to AtUGT78D2. The side chain of Asp380 of AtUGT78D2 forms a hydrogen bond with the 3‑OH 
of glucose, and the nitrogen in the backbone of Trp359 forms a hydrogen bond with the 4‑OH of glucose. The methyl group of the acetamido of 
UDP‑N‑acetylquinovosamine interacts hydrophobically with Phe238, Gln381, and Met288. The methyl group at carbon 5 interacts hydrophobi‑
cally with the backbone of Thr145 and the side chain of Ala146. b Docking of UDP‑N‑acetylquinovosamine UDP‑N‑acetylxylosamine The 3‑ and 
4‑hydroxy groups of N‑acetylxylosamine interact with the side chain of Asp380 and backbone NH group of Trp359 of AtUGT78D2. The methyl group 
of 2‑acetamido group in N‑acetylxylosamine was fitted into a hydrophobic pocket formed by Phe378, Gln381, and Met288
Fig. 3 Analysis of quercetin biotransformation product using E. coli 
strain QS‑1. P1 Quercetin 3‑O‑(N‑acetyl)glucosamine; P2 quercetin 
3‑O‑(N‑acetyl)quinovosamine; S, quercetin
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mutant strains, BgalU and Bpgm. The galU (glucose-
1-phosphate uridylyltransferase) gene, which is directly 
involved in the formation of UDP-glucose, was deleted 
in E. coli BL21(DE3). The pgm (phosphoglucomutase) 
mutant (Bpgm) has a higher level of UDP-N-acetylglu-
cosamine [17]. pC-DHR-D2 was transformed into BgalU 
and Bpgm. BL21(DE3) was used as a control. The pro-
duction of quercetin 3-O-(N-acetyl)quinovosamine was 
highest in BgalU (QS-3; 26.7  mg/L) (Fig.  4). Bpgm pro-
duced a comparable amount of quercetin 3-O-(N-acetyl)
quinovosamine (QS-2; 24.6 mg/L). In addition, the ratio 
of quercetin 3-O-(N-acetyl)glucosamine and quercetin 
3-O-(N-acetyl)quinovosamine was approximately 33–67 
in both strains. Our previous study on production of 
quercetin 3-O-(N-acetyl)glucosamine showed that BgalU 
was the most productive strain and that its production of 
minor product such as quercetin 3-O-glucose was lower 
than that of BL21 (DE3) or Bpgm [21]. We also observed 
the production of quercetin 3-O-glucose in QS-2. There-
fore, we used QS-3 for further study.
Next, we increased the conversion of UDP-N-acetylglu-
cosamine to UDP-N-acetylquinovosamine by introduc-
ing extra copies of Pdeg and Preq into the strain QS-4. 
As expected, the QS-4 strain (BgalU harboring pC-DHR-
D2 and pE-DHR) produced approximately 33.5 mg/L of 
quercetin 3-O-(N-acetyl)quinovosamine (Fig.  4). Also, 
the ratio of quercetin 3-O-(N-acetyl)glucosamine and 
quercetin 3-O-(N-acetyl)quinovosamine in this strain 
was 70–30, indicating that the production of byproduct 
was reduced in this strain.
The production of quercetin 3-O-(N-acetyl)quinovo-
samine and quercetin-3-O-(N-acetyl)glucosamine was 
monitored for 48  h. Quercetin was added periodically 
to the medium to a final concentration of 600  μM. The 
production of both compounds continued to increase 
until 36  h, at which point approximately 158.3  mg/L 
(323.7  μM) of quercetin-3-O-(N-acetyl)quinovosamine 
and 112.3  mg/L (222.4  μM) of quercetin-3-O-(N-acetyl)
glucosamine had been produced.
Synthesis of luteolin 7‑O‑(N‑acetyl)glucosaminuronic acid
We adopted UDP-N-acetylglucosamine dehydroge-
nase (UDP-GlcNAc 6-DH) from B. cereus NVH 391-98 
to synthesize UDP-N-acetylglucosaminuronic acid in 
E. coli. UDP-GlcNAc 6-DH converts UDP-N-acetyl-
glucosamine into UDP-N-acetylglucosaminuronic acid 
[13]. AmUGT10, which uses UDP-glucuronic acid as 
a sugar donor and transfers glucuronic acid onto the 
7-hydroxy group of luteolin, was employed as a glyco-
syltransferase. We observed that AtUGT78D2, which 
used UDP-glucose as a sugar donor, could also use UDP-
N-acetylglucosamine even though the catalytic efficiency 
of UDP-N-acetylglucosamine, was lower than that of 
UDP-glucose [21]. Thus, we assumed that AmUGT10 
could use UDP-N-acetylglucosaminuronic acid as a sugar 
donor because of the structural similarity of UDP-glu-
curonic acid and UDP-N-acetylglucosaminuronic acid. 
Both AmUGT10 and UDP-GlcNAc 6-DH were subcloned 
into E. coli expression vector pCDFDuet and the result-
ing construct pC-6DH-AmUGT was transformed into E. 
coli BL21 (DE3). Analysis of the biotransformation prod-
uct of luteolin in the resulting transformant (LNAGA-1 
in Table 1) showed a new peak with a molecular mass of 
462 Da (data not shown), which did not match with the 
predicted molecular mass of luteolin O-N-acetylglucosa-
minuronic acid (503 kDa). It was assumed that the avail-
ability of UDP-glucuronic acid in E. coli was likely to be 
higher than that of UDP-N-acetylglucosaminuronic acid. 
In order to increase the substrate of UDP-GlcNAc 6-DH, 
we used two mutant strains, B-gal and B-pgm. These two 
mutant strains were show to be effective for the synthe-
sis of quercetin 3-O-(N-acetyl)glucosamine and quercetin 
3-O-(N-acetyl)quinovosamine [21]. pC-6DH-AmUGT 
was transformed into B-galU and B-pgm. The resulting 
transformans (LNAGA-2 and LNAGA-3 in Table 1) were 
used for the biotransformation of luteolin. As shown in 
Fig. 5a, a new peak appeared in the culture filtrate of both 
transformans and its retention time was slight different 
from that of luteolin 7-O-glucuronic acid. The molecular 
mass of the product was 503 Da (Fig. 5c). In addition, the 
structure of the product was determined using NMR (see 
“Methods” section) and the structure was determined 
to be luteolin 7-O-(N-acetyl)glucosaminuronic acid. 
LNAGA-3 produced approximately twofold more luteo-
lin 7-O-(N-acetyl)glucosaminuronic acid than LNAGA-2 
(46.0 vs. 23. 9  mg/L), indicating that pgm mutant was 
more effective than galU mutant for the production of 
luteolin 7-O-(N-acetyl)glucosaminuronic acid.
Fig. 4 Comparison of production of quercetin 3‑O‑quinovosamine 
in different E. coli strains. 100 μM quercetin (30.2 mg/L) was added to 
the each culture. Approximately 4.6 mg/L of quercetin 3‑O‑glucose 
was detected in culture filtrate of the strain QS‑2. All the added 
quercetin was consumed in the strain QS‑4
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Next, we optimized the production of luteolin 7-O-(N-
acetyl)glucosaminuronic acid using LNAGA-3. First, 
the effect of cell concentration was examined. Cell con-
centration was adjusted from 1 to 25 at OD600. The pro-
duction of luteolin 7-O-(N-acetyl)glucosaminuronic 
acid continued to increase until OD600 =  22 (final titer 
65  mg/L), after which it decreased. Using LNAGA-3 at 
a concentration of OD600 = 22, the production of luteo-
lin 7-O-(N-acetyl)glucosaminuronic acid was monitored 
for 48  h. Due to the low solubility of luteolin, 100  μM 
of luteolin (approximately 28.6  mg/L) was added peri-
odically (at 0, 3, 6, 9 and 12 h, for a total of 500 μM of 
luteolin). The production of luteolin 7-O-(N-acetyl)
glucosaminuronic acid continued to increase for 48  h. 
At this time, approximately 172.5  mg/L (approximately 
344  μM) luteolin 7-O-(N-acetyl)glucosaminuronic acid 
was produced.
Synthesis of quercetin 3‑O‑(N‑acetyl)xylosamine
UDP-N-acetylxylosamine is synthesized from UDP-
N-acetylglucosaminuronic acid by UDP-N-acetylxy-
losamine synthase (UXNAcS; Fig. 1). The UXNAcS gene 
was synthesized based on its published sequence [13]. In 
order to synthesize UDP-N-acetylxylosamine in E. coli, 
UXNAcS was subcloned into E. coli expression vectors 
along with UGlcNAcDH. The UGT was selected based 
on molecular docking. AtUGT78D2 appeared likely to 
use UDP-N-acetylxylosamine. The 3- and 4-hydroxy 
groups of N-acetylxylosamine interacted with the side 
chain of Asp380 and backbone NH group of Trp359 
(Fig.  2b). The methyl group of 2-acetamido group in 
N-acetylxylosamine was fitted into a hydrophobic pocket 
formed by Phe378, Gln381, and Met288 (Fig. 2b).
In order to synthesize quercetin 3-O-(N-acetyl)
xylosamine, three genes, UGlcNAcDH, UXNAcS, and 
AtUGT78D2, were transformed into E. coli BL21 (DE3). 
The transformant (Q-NX-1) was used for the biotransfor-
mation of quercetin and the biotransformation product 
was analyzed using HPLC. Three new peaks appeared. 
The results of a previous study [21] indicated that P1 
and P2 in Fig.  6 were likely to be quercetin 3-O-gluco-
side, and quercetin 3-O-(N-acetyl)glucosamine, respec-
tively based on comparison of their retention times 
with those of authentic quercetin 3-O-glucoside, and 
quercetin 3-O-(N-acetyl)glucosamine (data not shown). 
AtUGTT78D2 showed affinity for UDP-glucose and 
UDP-N-acetylglucosamine [17]. P3 was not observed 
previously and its molecular mass was 505.1  Da, which 
matched the predicted molecular mass of quercetin 
3-O-(N-acetyl)xylosamine. This molecular structure was 
confirmed by NMR.
Although quercetin 3-O-(N-acetyl)xylosamine was 
synthesized in E. coli, more quercetin 3-O-glucoside 
was produced in the strain Q-NX-1. We used different 
E. coli mutants such as BgalU and Bpgm along with dif-
ferent E. coli expression vectors to increase the produc-
tion of quercetin 3-O-(N-acetyl)xylosamine. The strain 
Bpgm was more effective than the wild type or BgalU. 
In addition, the higher copy number of expression vec-
tor pCDFDuet was better than the lower copy number 
vector pACYCDuet (Fig.  6). Therefore, the best strain 
for the synthesis of quercetin 3-O-(N-acetyl)xylosamine 
Fig. 5 Analysis of reaction products of strain LNAGA‑2. a Reaction product from strain LNAGA‑2; b standard luteolin 7‑O‑glucuronic acid; c the 
mass of the reaction product
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was QNX-4; that is, Bpgm harboring pC-6-DH-UXNAcS 
and pG-D2 (final titer 22.1  mg/L). QNX-4 produced 
about 2.7-fold more quercetin 3-O-N-acetylxylosamine 
than did QNX-1 (8.1  mg/L). Cell concentration was 
optimized. The concentration of Bpgm harboring pC-
6-DH-UXNAcS and pG-D2 was adjusted from 1–10 and 
quercetin (100 μM) was added at 0, 1.5, 4.5 and 6 h. The 
mixture was incubated for 8 h at 30 °C. The production of 
quercetin 3-O-N-acetylxylosamine continued to increase 
until OD600 =  8. At higher cell concentrations, produc-
tion decreased. Using strain QNX-4 with an initial cell 
concentration of 8 at OD600, 160.8  mg/L (318.4  μM) of 
quercetin 3-O-(N-acetyl)xylosamine was synthesized in 
8 h from 185.6 mg/L (400 μM) quercetin.
Discussion
We synthesized three novel flavonoid glycosides, querce-
tin 3-O-(N-acetyl) quinovosamine, luteolin O-(N-acetyl)
glucosaminuronic acid, and quercetin 3-O-(N-acetyl)
xylosamine. These flavonoid glycones have not, to our 
knowledge, been synthesized previously by any means 
using the strains developed in this study, diverse novel 
flavonoid glycosides could be synthesized.
Nucleotide sugar biosynthesis starts from glucose 
1-phosphate. UDP-glucose and TDP-glucose are two 
central nucleotide sugars. For the synthesis of nucleotide 
amino sugars in E. coli, conversion of glucose 1-phosphate 
to glucose 6-phosphate by phosphoglucose mutase (pgm) 
is a key step (Fig. 1). Deletion of galU, which converts glu-
cose 1-phosphate into UDP-glucose and thereby increases 
the pool of glucose 1-phosphate, resulted in increased 
biosynthesis of flavonoid amino sugars. Deleting the pgm 
gene also increased the production of flavonoid amino 
sugars. Synthesis of luteolin 7-O-(N-acetyl)glucosaminu-
ronic acid and quercetin 3-O-(N-acetyl)xylosamine was 
more effective in the pgm mutant than in the galU mutant. 
However, high levels of quercetin 3-O-(N-acetyl)quinovo-
samine were produced in the galU mutant. The choice of 
the mutant affects the production of byproduct(s). The 
galU mutant produced more quercetin 3-O-(N-acetyl)glu-
cosamine than the pgm mutant when quercetin 3-O-(N-
acetyl)xylosamine was synthesized. The pgm mutant 
synthesized quercetin 3-O-glucose as well as quercetin 
3-O-(N-acetyl)glucosamine as a byproduct during querce-
tin 3-O-(N-acetyl)quinovosamine synthesis. Therefore, we 
chose the mutant that produced less byproduct and more 
target compound.
The initial experiment of quercetin 3-O-(N-acetyl)qui-
novosamine synthesis showed that more of the byprod-
uct quercetin 3-O-(N-acetyl)glucosamine was produced 
than quercetin 3-O-(N-acetyl)quinovosamine. We found 
that there were two possible ways to reduce the produc-
tion of quercetin 3-O-(N-acetyl)quinovosamine. The first 
one was to increase the pool of UDP-N-acetylglucosa-
mine. The other was to increase the conversion rate of 
UDP-N-acetylglucosamine to UDP-N-acetylquinovosa-
mine. We used an E. coli strain that was engineered to 
increase the supply of UDP-N-acetylglucosamine and it 
turned out that more quercetin 3-O-(N-acetyl)quinovo-
samine was produced than quercetin 3-O-(N-acetyl)
glucosamine. The UDP-N-acetylglucosamine could be 
a substrate of both AtUGT78D2 for the synthesis of 
quercetin 3-O-(N-acetyl)quinovosamine and Pdeg for the 
synthesis of UDP-(N-acetyl)quinovosamine. It was likely 
that conversion of UDP-N-acetylglucosamine into UDP-
(N-acetyl)quinovosamine by Pdeg and Preq was faster 
than that of UDP-N-acetylglucosamine into quercetin 
3-O-(N-acetyl)glucosamine. Increase in the conversion of 
UDP-N-acetylglucosamine into UDP-N-acetylquinovo-
samine also contributed to increase the final yield of the 
quercetin 3-O-(N-acetyl)quinovosamine and to decrease 
the production of quercetin 3-O-(N-acetyl)glucosamine.
The AtUGT78D2 used in this study was promiscu-
ous for its sugar donor, which led to the production of 
byproducts. For example, in the synthesis of quercetin 
3-O-(N-acetyl)xylosamine, two byproducts, quercetin 
3-O-glucose and quercetin 3-O-(N-acetyl)glucosamine 
were synthesized. This was because the endogenous 
amounts of UDP-glucose and UDP-(N-acetyl)glucosa-
mine were higher than that of UDP-(N-acetyl)xylosamine. 
By manipulating the nucleotide pathway, more quercetin 
3-O-(N-acetyl)xylosamine was synthesized than quercetin 
3-O-glucose and quercetin 3-O-(N-acetyl)glucosamine. 
The endogenous concentration of the sugar donor was a 
critical factor in the final yield of target molecule.
Quercetin 3-O-glucoside was not detected during 
quercetin 3-O-(N-acetyl)quinovosamine biosynthesis 
(Fig.  3) while its production was observed during the 
Fig. 6 Production of quercetin 3‑O‑(N‑acetyl)xylosamine in different 
E. coli strains
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synthesis of quercetin 3-O-(N-acetyl)xylosamine (Fig. 6). 
The genes for UDP-(N-acetyl)quinovosamine were differ-
ent from that for UDP-(N-acetyl)xylosamine. The cata-
lytic parameters of each protein encoded by each gene 
would be different, which results in the different conver-
sion rate of UDP-(N-acetyl)glucosamine. Therefore, the 
availability of a nucleotide sugar for each flavonoid glyco-
sides was different, which might lead to this observation. 
The another possible explanation is that AtUGT78D2 
might have much better catalytic efficiency for UDP-
(N-acetyl)quinovosamine than either UDP-glucose or 
UDP-(N-acetyl)xylosamine and the catalytic efficiency 
of AtUGT7D2 was better for UDP-glucose than UDP-
(N-acetyl)xylosamine. Due to it, quercetin 3-O-glucose 
was not found during quercetin 3-O-(N-acetyl)qui-
novosamine biosynthesis but observed during quercetin 
3-O-(N-acetyl)xylosamine biosynthesis.
Conclusions
Nucleotide sugars are used to synthesize diverse glycones. 
Many nucleotide sugars have been identified and the cor-
responding genes have been cloned. However, application 
of these nucleotide sugars to the synthesis of glycones is 
an emerging field. We reconstructed the E. coli nucleotide 
pathway for the synthesis of UDP-quinovosamine, UDP-
N-acetylglucosaminuronic acid and UDP-N-acetylxylosa-
mine and synthesized three novel flavonoid glycones. E. 
coli mutants (deleted in galU or pgm) were used and the 
novel nucleotide biosynthetic genes were introduced. 
Using this approach, 158.3 mg/L quercetin 3-O-(N-acetyl)
quinovosamine, 172.5  mg/L luteolin 7-O-(N-acetyl)glu-
cosaminuronic acid, and 160.8  mg/L quercetin 3-O-(N-
acetyl)xylosamine were synthesized.
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